| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |